Sucampo Pharma Revenue, Profits - SCMP Annual Income Statement

Add to My Stocks
$18 $0 (0%) SCMP stock closing price Feb 13, 2018 (Closing)

Financial analysis of Sucampo Pharma involves more than just checking the Sucampo Pharma stock price, by looking at the financial statements of the company in detail. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the SCMP stock is bound to reflect the impact of the YOY growth of 50.18%. Along with Sucampo Pharma assets and Sucampo Pharma free cash flow, Sucampo Pharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2016 is $18.48M and the 2016 revenue is $230.05M.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Sucampo Pharma Revenues or Net Sales
230.05M153.18M115.45M89.59M81.48M54.76M61.87M67.35M112.12M
Cost Of Goods Sold (COGS)76M36.73M16.26M12.4M3.03M----
Sucampo Pharma Gross Profit
154.05M116.44M99.18M77.19M78.45M54.76M61.87M67.35M112.12M
Research & Development Expense46.61M33.63M20.56M21.52M21.29M33.49M23.95M32.9M46.18M
Selling General & Admin Expense53.56M38.35M51.38M46.47M48.84M38.95M38.06M32.1M34.87M
Income Before Depreciation Depletion Amortization53.87M44.45M27.23M9.19M8.31M-17.68M-0.15M2.34M31.07M
Depreciation Depletion Amortization---------
Non Operating Income-15.74M6.07M1.42M3.04M1.78M-1.77M-3.09M1.18M2.04M
Interest Expense23.76M6.85M1.52M1.89M2.34M2.45M---
Sucampo Pharma Pretax Income
14.37M43.67M27.13M10.34M7.75M-21.91M-3.32M3.53M33.11M
Provision for Income Taxes-4.11M10.3M14M3.92M2.91M-4.6M-0.56M4.29M8.16M
MinorityInterest---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations18.48M33.37M13.12M6.41M4.83M-17.3M-2.75M-0.76M24.95M
Extraordinary Items & Discontinued Operations---------
Sucampo Pharma Profit/ Loss (Net Income)
18.48M33.37M13.12M6.41M4.83M-17.3M-2.75M-0.76M24.95M
Average Shares used to compute Diluted EPS43.75M45.68M44.51M42.54M41.79M41.84M41.85M41.84M41.97M
Average Shares used to compute Basic EPS42.79M44.15M43.69M41.72M41.66M41.84M41.85M41.84M41.79M
Income Before Nonrecurring Items66.21M43.51M17.9M9.4M4.84M-24.52M-2.76M-0.76M24.95M
Income from Nonrecurring Items-47.73M-10.14M-4.77M-2.98M-7.22M---
Sucampo Pharma Earnings Per Share Basic Net
0.430.760.300.150.12-0.41-0.07-0.020.60
Sucampo Pharma Earnings Per Share Diluted Net
0.420.730.290.150.12-0.41-0.07-0.020.59
EPS Diluted Before Nonrecurring Items1.510.990.400.220.12-0.59-0.07-0.020.59
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The key things to look for in an income statement while doing Sucampo Pharma stock analysis are:

  • Topline: A growing topline, as seen from the Sucampo Pharma revenue chart, as is the case with Sucampo Pharma indicates a growing business. One needs to compare the YoY topline or sales growth of SCMP stock with its peers like HPTX stock and RDUS stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: Most businesses like Sucampo Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the SCMP income statement, one can check the Sucampo Pharma historical stock prices to check how the price has moved with time.

Sucampo Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
3.33
Operating Margin
34.6
Net Profit Margin
16.9
Dividend Yield
0%